SCANCARELLO, CHIARA
SCANCARELLO, CHIARA
Efficacy of 3 Tesla Functional Magnetic Stimulation for the Treatment of Female Urinary Incontinence
2022-01-01 Braga, A.; Castronovo, F.; Caccia, G.; Papadia, A.; Regusci, L.; Torella, M.; Salvatore, S.; Scancarello, C.; Ghezzi, F.; Serati, M.
Hysteropexy and Anterior Vaginal Native Tissue Repair in Women with Anterior and Central Compartment Prolapse: A Long Term Follow-Up
2023-01-01 Serati, M.; Salvatore, S.; Torella, M.; Scancarello, C.; De Rosa, A.; Ruffolo, A. F.; Caccia, G.; Ghezzi, F.; Papadia, A.; Baruch, Y.; Braga, A.
Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder?
2022-01-01 Serati, M.; Cantaluppi, S.; Coluccia, A. C.; Scancarello, C.; Cimmino, C.; Braga, A.; Salvatore, S.; Finazzi Agro, E.; Ghezzi, F.
Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up
2022-01-01 Braga, A.; Castronovo, F.; Ottone, A.; Torella, M.; Salvatore, S.; Ruffolo, A. F.; Frigerio, M.; Scancarello, C.; De Rosa, A.; Ghezzi, F.; Papadia, A.; Caccia, G.; Serati, M.
The subjective and objective very long-term outcomes of TVT in the COVID era: A 20-year follow-up
2022-01-01 Braga, A.; Caccia, G.; Papadia, A.; Castronovo, F.; Salvatore, S.; Scancarello, C.; Torella, M.; Ghezzi, F.; Serati, M.
Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity
2024-01-01 Serati, M.; Campitiello, M. R.; Torella, M.; Mesiano, G.; Scancarello, C.; Ghezzi, F.; Papadia, A.; Gamarra, E.; Caccia, G.; Braga, A.
When does oasis cause de novo pelvic floor dysfunction? role of the surgeon's skills
2022-01-01 Serati, M.; Ruffolo, A. F.; Scancarello, C.; Braga, A.; Salvatore, S.; Ghezzi, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Efficacy of 3 Tesla Functional Magnetic Stimulation for the Treatment of Female Urinary Incontinence | 1-gen-2022 | Braga, A.; Castronovo, F.; Caccia, G.; Papadia, A.; Regusci, L.; Torella, M.; Salvatore, S.; Scancarello, C.; Ghezzi, F.; Serati, M. | |
| Hysteropexy and Anterior Vaginal Native Tissue Repair in Women with Anterior and Central Compartment Prolapse: A Long Term Follow-Up | 1-gen-2023 | Serati, M.; Salvatore, S.; Torella, M.; Scancarello, C.; De Rosa, A.; Ruffolo, A. F.; Caccia, G.; Ghezzi, F.; Papadia, A.; Baruch, Y.; Braga, A. | |
| Is urodynamic evaluation able to change and improve the management of women with idiopathic overactive bladder? | 1-gen-2022 | Serati, M.; Cantaluppi, S.; Coluccia, A. C.; Scancarello, C.; Cimmino, C.; Braga, A.; Salvatore, S.; Finazzi Agro, E.; Ghezzi, F. | |
| Medium Term Outcomes of TVT-Abbrevo for the Treatment of Stress Urinary Incontinence: Efficacy and Safety at 5-Year Follow-Up | 1-gen-2022 | Braga, A.; Castronovo, F.; Ottone, A.; Torella, M.; Salvatore, S.; Ruffolo, A. F.; Frigerio, M.; Scancarello, C.; De Rosa, A.; Ghezzi, F.; Papadia, A.; Caccia, G.; Serati, M. | |
| The subjective and objective very long-term outcomes of TVT in the COVID era: A 20-year follow-up | 1-gen-2022 | Braga, A.; Caccia, G.; Papadia, A.; Castronovo, F.; Salvatore, S.; Scancarello, C.; Torella, M.; Ghezzi, F.; Serati, M. | |
| Urethral Bulking Agents for the Treatment of Urinary Incontinence: Efficacy, Safety, and Impact on the Overactive Bladder Symptoms with an Underlying Detrusor Overactivity | 1-gen-2024 | Serati, M.; Campitiello, M. R.; Torella, M.; Mesiano, G.; Scancarello, C.; Ghezzi, F.; Papadia, A.; Gamarra, E.; Caccia, G.; Braga, A. | |
| When does oasis cause de novo pelvic floor dysfunction? role of the surgeon's skills | 1-gen-2022 | Serati, M.; Ruffolo, A. F.; Scancarello, C.; Braga, A.; Salvatore, S.; Ghezzi, F. |